Prevention of cell death by antibodies selected from intracellular combinatorial libraries

Jia Xie1, Kyungmoo Yea2, Hongkai Zhang1

  • 1Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Chemistry & Biology
|January 21, 2014
PubMed

Insights

Researchers identified rare antibodies that protect cells from rhinovirus by inhibiting viral protease. This study offers insights into cell death mechanisms and viral infection dynamics.

Area of Science:

  • Cell Biology
  • Virology
  • Immunology

Background:

  • Cell death is a critical biological process.
  • Understanding cell death mechanisms aids in developing therapeutic strategies.
  • Rhinovirus infections can lead to significant cellular damage.

Purpose of the Study:

  • To identify molecules that protect cells from rhinovirus-induced cell death.
  • To elucidate the mechanisms by which these protective molecules function.
  • To analyze the dynamics of an in vitro selection process involving competing biological systems.

Main Methods:

  • Intracellular combinatorial antibody libraries were employed for selection.
  • Deep sequencing was used to monitor antibody enrichment over selection rounds.
  • The function of selected antibodies was assessed by their ability to inhibit viral protease.

Main Results:

  • Rare antibodies were successfully selected that conferred protection against rhinovirus infection.
  • These protective antibodies were found to inhibit the virus-encoded protease essential for viral maturation.
  • Deep sequencing provided a detailed view of the selection process, highlighting competition between protected and unprotected cells.

Conclusions:

  • Inhibiting viral protease is a viable strategy to protect cells from rhinovirus infection.
  • Intracellular antibody selection is an effective method for discovering antiviral molecules.
  • The study provides a unique "test tube" model for observing evolutionary competition between viral and host systems.

Related Concept Videos

Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
3.9K
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
66.2K
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
99